跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Gemcitrex-200
Approved
STANDARD
Gemcitrex-200
Shilpa Medicare Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f1995dfb4302f4cb
Company
Shilpa Medicare Limited
Type
Standard
Approval Details
Approval Id
f1995dfb4302f4cb
Drug Approval Philippines Name
Gemcitrex-200
Product Name
Gemcitrex-200
Registration Number
DRP-9563
Brand Name
Gemcitrex-200
Generic Name
Gemcitabine (as hydrochloride)
Dosage Form
Lyophilized Powder for Injection for I.V. Infusion
Dosage Strength
200 mg
Manufacturer
Shilpa Medicare Limited
Importer
Ambica International Corporation
Distributor
Ambica International Corporation
Company Detail Path
/organization/shilpa-medicare-limited
Issuance Date
24 February 2021
Expiry Date
24 February 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f1995dfb4302f4cb
Type
Standard
Back to Philippines FDA Approvals
Gemcitrex-200 - Philippines FDA Drug Approval Details